Feng Yin

415 total citations
5 papers, 34 citations indexed

About

Feng Yin is a scholar working on Oncology, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Feng Yin has authored 5 papers receiving a total of 34 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Molecular Biology and 1 paper in Health, Toxicology and Mutagenesis. Recurrent topics in Feng Yin's work include Acute Myeloid Leukemia Research (1 paper), Bone health and treatments (1 paper) and Cancer Research and Treatments (1 paper). Feng Yin is often cited by papers focused on Acute Myeloid Leukemia Research (1 paper), Bone health and treatments (1 paper) and Cancer Research and Treatments (1 paper). Feng Yin collaborates with scholars based in China, Taiwan and Czechia. Feng Yin's co-authors include Xiaoxia Huang, Wenjie Mei, Xiaoting Huang, Ruotong Liu, Jiayi Qian, Shuyuan Zhou, Ying Ding, Wen‐Hung Kuo, Dong Li and Dar‐Ren Chen and has published in prestigious journals such as RSC Advances, Journal of environmental chemical engineering and Acta Pharmaceutica Sinica B.

In The Last Decade

Feng Yin

5 papers receiving 34 citations

Peers

Feng Yin
Comparison fields: 5 of 31
  • Molecular Biology 16
  • Oncology 11
  • Cancer Research 10
  • Inorganic Chemistry 5
  • Organic Chemistry 4
Replace Jerzy Błaszczyk with:
Jerzy Błaszczyk Poland
Tanisha Meeuwsen United States
Jocelyn Zoll United States
Yujia He China
Anna Mollin United States
Jana Václavková Czechia
Ravi Visswanathan United States
Lenora A. Pluchino United States
Barbara Wölfel Germany
Shayan Sadre United States
Jerzy Błaszczyk Poland View profile →
Citations per field, relative to Feng Yin
Feng Yin · 1×
Citations per year, relative to Feng Yin
Feng Yin · 1×

Countries citing papers authored by Feng Yin

Since Specialization
Citations

This map shows the geographic impact of Feng Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Yin more than expected).

Fields of papers citing papers by Feng Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Yin. The network helps show where Feng Yin may publish in the future.

Co-authorship network of co-authors of Feng Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Yin. A scholar is included among the top collaborators of Feng Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Yin. Feng Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
# Work Indexed citations
1 3
2 3
3 16
4 7
5
EORTC QLQ-BM22 quality of life evaluation and pain outcome in patients with bone metastases from breast cancer treated with zoledronic acid.
5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026